CausalSentinel

Protein Dossier — KDR (Vascular endothelial growth factor receptor 2)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Diagnoses - main ICD10: R07 Pain in throat and chest 0.0564 0.0245 0.0213 Wald ratio 1 cis NA
Diagnoses - main ICD10: R14 Flatulence and related conditions 0.368 0.173 0.0332 Wald ratio 1 cis NA
Potassium in urine 0.0117 0.00589 0.0469 Wald ratio 1 cis NA
Cough on most days -0.0605 0.0313 0.0534 Wald ratio 1 cis NA
Diagnoses - main ICD10: K35 Acute appendicitis 0.137 0.0731 0.0611 Wald ratio 1 cis NA
Diagnoses - main ICD10: I48 Atrial fibrillation and flutter -0.108 0.0615 0.0778 Wald ratio 1 cis NA
Non-cancer illness code self-reported: psoriasis 0.0879 0.0502 0.0795 Wald ratio 1 cis NA
Weight 0.00884 0.00512 0.0846 Wald ratio 1 cis NA
Hearing difficulty or problems: Yes 0.0167 0.00984 0.0902 Wald ratio 1 cis NA
Eye problems or disorders: Cataract 0.0511 0.0302 0.091 Wald ratio 1 cis NA
Diagnoses - main ICD10: G47 Sleep disorders -0.149 0.0886 0.0927 Wald ratio 1 cis NA
Diagnoses - main ICD10: K57 Diverticular disease of intestine -0.0734 0.044 0.0954 Wald ratio 1 cis NA
…and 55 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-3651_50_5 VEGF sR2 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

79 association rows across 37 traits (66 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating KDR levels (id: OID00677_OID21497) 1e-1414 rs34231037 7 GCST90860021 no MR -> candidate analysis
Circulating KDR levels (id: OID00780_OID21497) 7e-1370 rs34231037 7 GCST90860113 no MR -> candidate analysis
KDR protein levels 2e-231 rs35389572 7 GCST90469672 no MR -> candidate analysis
Vascular endothelial growth factor receptor 2 levels (KDR.36 1e-70 rs34231037 2 GCST90243323 no MR -> candidate analysis
Serum levels of protein KDR 5e-53 rs34231037 3 GCST90088480 no MR -> candidate analysis
Vascular endothelial growth factor receptor 2 levels 2e-48 rs2305948 8 GCST90250164 no MR -> candidate analysis
Endometriosis 2e-45 rs10517343 6 GCST90841381 no MR -> candidate analysis
Clinical endometriosis 8e-31 rs10517343 2 GCST90841386 no MR -> candidate analysis
Endometriosis (MTAG) 7e-27 rs1903068 2 GCST90570207 no MR -> candidate analysis
Dupuytren’s disease 7e-23 rs73818546 2 GCST90301252 no MR -> candidate analysis
Self-reported endometriosis 9e-22 rs10517343 1 GCST90841387 no MR -> candidate analysis
Blood protein levels 6e-21 rs2305948 1 GCST006585 no MR -> candidate analysis
…and 25 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

Top diseases by Open Targets association (of 1602 total). Associations are loci, not causal claims. The causal-status column is a four-state triage per pair: established (curated) = a curated clinical assertion exists (ClinGen/G2P/GEL/Orphanet/ClinVar — any validity level, MR adds little); exploratory rare-variant signal = ExWAS burden evidence without curation — a candidate NEW gene-disease relationship; common-variant locus = GWAS signal, classic pQTL-MR territory; multi-layer = burden+GWAS together, an allelic-series candidate (the strongest causal setup). Burden estimand is carrier-vs-noncarrier, not per-SD MR.

Disease genetic assoc. burden (ExWAS) causal status MR status
neoplasm 0.285 established (curated) MR: beta=0.0663, p=0.149 (cis)
endometriosis 0.88 common-variant locus no MR -> candidate analysis
capillary infantile hemangioma 0.547 established (curated) no MR -> candidate analysis

Of the 3 rows above, 2 have no MR estimate in this resource. Across all retrieved diseases for this gene: 0 exploratory rare-variant signal(s), 0 multi-layer (allelic-series candidate) pair(s). Final triage still belongs to a statistical geneticist.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 0 known modulators (TEL/KDR)
gnomAD constraint pLI=1, LOEUF=0.345 — LoF-INTOLERANT
GWAS Catalog 53 unique SNPs / 106 rows
ClinVar 277 records; 0 pathogenic in sample of 30
PharmGKB/ClinPGx 7 clinical annotations across 3 drugs

Caveats declared by the tools

Sources

Provenance